SSGI Inc. (OTCMKTS:VICP – Get Free Report) fell 27.3% during trading on Friday. The company traded as low as $0.40 and last traded at $0.40. 500 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 2,947 shares. The stock had previously closed at $0.5499.
SSGI Price Performance
The stock has a market capitalization of $12.83 million, a PE ratio of -13.33 and a beta of 5.37. The company’s 50 day moving average price is $0.97 and its two-hundred day moving average price is $1.29.
About SSGI
Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc and changed its name to Vicapsys Life Sciences, Inc in September 2017.
Featured Stories
- Five stocks we like better than SSGI
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for SSGI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SSGI and related companies with MarketBeat.com's FREE daily email newsletter.
